Healthcare Triangle, Inc.
No SEC Form 4 filings for $HCTI in the last 30 days.
See all $HCTI insider activity →Healthcare Triangle (Nasdaq: HCTI) reported Q2 2026 revenue of $9.19 million, up 158% year over year, and gross profit of $2.07 million, up 322%. The AI platform contributed about 69% of revenue and gross margin rose to 22.5% from 13.8%. The Teyame and Datono acquisition added $6.31 million revenue. Stockholders’ equity rose to $49.1 million from $9.9 million.
Healthcare Triangle, Inc. (Nasdaq: HCTI) reported Q2 2026 revenue of $9.19M, up 158% year over year, and gross profit of $2.07M, up 322%. The AI platform contributed about 69% of revenue and gross margin rose to 22.5% from 13.8%. The Teyame and Datono acquisition contributed $6.31M revenue. Stockholders’ equity rose to $49.1M from $9.9M.
Healthcare Triangle (Nasdaq: HCTI) said it signed a non-binding LOI to acquire a 51% stake in CosmoInnovations (CosmoAesthetics Pty Ltd). Proposed consideration is $23.5 million over three years via cash, equity, and performance milestones. The deal would add 27 granted international patents and 61 pending applications, targeting over $50 million cumulative revenue in three years.
Over the past 7 days, alphai's AI scored 2 news stories mentioning HCTI (Healthcare Triangle, Inc.). Coverage has skewed bullish: 2 bullish, 0 neutral, and 0 bearish.
Recent HCTI coverage spans corporate actions, earnings and financial news.
The quarter shows a step-change in profitability and balance-sheet strength, likely supporting near-term bullish positioning but increasing sensitivity to post-acquisition integration and margin sustainability.
The quarter shows strong post-acquisition momentum (Teyame and Datono) with margin expansion and a balance-sheet equity jump.
Potential shift from healthcare IT services to a product-led medtech and consumer-health platform via a majority stake acquisition.
The dilution from newly issued shares is explicitly framed as strengthening compliance with Nasdaq’s new $5M MVLS continued listing standard.
Dilutive equity issuance tied to acquisitions and a securities exchange agreement, likely increasing near-term float and overhang risk.
alphai scores every news story that mentions HCTI with an AI model for sentiment and relevance, and aggregates insider trades from Healthcare Triangle, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Healthcare Triangle (Nasdaq: HCTI) reported Q2 2026 revenue of $9.19 million, up 158% year over year, and gross profit of $2.07 million, up 322%. The AI platform contributed about 69% of revenue and gross margin rose to 22.5% from 13.8%. The Teyame and Datono acquisition added $6.31 million revenue. Stockholders’ equity rose to $49.1 million from $9.9 million.
4 min readHealthcare Triangle, Inc. (Nasdaq: HCTI) reported Q2 2026 revenue of $9.19M, up 158% year over year, and gross profit of $2.07M, up 322%. The AI platform contributed about 69% of revenue and gross margin rose to 22.5% from 13.8%. The Teyame and Datono acquisition contributed $6.31M revenue. Stockholders’ equity rose to $49.1M from $9.9M.
4 min readHealthcare Triangle (Nasdaq: HCTI) said it signed a non-binding LOI to acquire a 51% stake in CosmoInnovations (CosmoAesthetics Pty Ltd). Proposed consideration is $23.5 million over three years via cash, equity, and performance milestones. The deal would add 27 granted international patents and 61 pending applications, targeting over $50 million cumulative revenue in three years.
4 min readHealthcare Triangle, Inc. (Nasdaq: HCTI) said it completed on July 24, 2026 the issuance of 12,546,540 common shares tied to its Teyame AI LLC acquisition and a SecureKloud Technologies Ltd. share exchange. Shares outstanding rose to 14,644,322. The company cited Nasdaq’s new $5 million MVLS continued listing standard, estimating MVLS of about $23.87 million as of July 28, 2026.
4 min readHealthcare Triangle, Inc. (HCTI) filed an SEC Form 8-K — Unregistered Sales of Equity Securities. false 0001839285 0001839285 2026-07-28 2026-07-28 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Repor
2 min readHealthcare Triangle, Inc. (NASDAQ: HCTI) said it appointed Sumit Ganguli as Chairman and CEO of Purpose Health, its wholly owned AI-led healthcare services subsidiary. Purpose Health will build AI infrastructure and managed services for providers, payors, and life sciences clients, targeting multi-year recurring revenue. The release cites Ganguli’s prior scaling to about $175M revenue (2009-2024).
3 min readHealthcare Triangle, Inc. (HCTI) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. false 0001839285 0001839285 2026-07-17 2026-07-17 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Repor
2 min readHealthcare Triangle, Inc. (HCTI) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. false --12-31 0001839285 0001839285 2026-06-24 2026-06-24 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date
4 min readHealthcare Triangle, Inc. (HCTI) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 4 ea029478001ex10-1.htm SECURITIES PURCHASE AGREEMENT, DATED AS OF JUNE 12, 2026, BY AND AMONG HEALTHCARE TRIANGLE, INC. AND THE PURCHASERS PARTY THERETO Exhibit 10.1 SECURITIES PURCHASE AGREEMENT THIS SECURITIES PURCHASE AGREEMENT (the “ Agreement ”) is made as of June 1
6 min readHealthcare Triangle Inc. has entered into a platform development agreement with Securekloud and Blockedge on April 7, according to an SEC filing. The healthcare information technology company specializes in cloud services, data science, and professional and managed services for the healthcare and life sciences industries. This agreement is part of Healthcare Triangle's ongoing initiatives, which include expanding its reach in Africa and launching an Agentic AI Agent for healthcare services.
3 min read
